EU RESEARCHERS USE NANOPARTICLES TO HELP DRUGS TARGET TUMOURS
January 1st, 2009
BY KEITH NUTHALL
CHEMOTHERAPY and radiotherapy maybe effective against cancer, but sometimes they are a sledgehammer to crack a nut, causing patients to suffer from so many side-effects they sometimes wished their tumours had been left alone.
And so it has long been the aim of pharmaceutical companies and cancer researchers to devise means of targeting therapies, so that it is the tumour that gets harmed, while the patient feels OK.
Now, a new four-year European Union (EU) research project is trying to use nanotechnology - which is at the cutting edge of so many ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.